The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial bril- lation patients undergoing transoesophageal echocardiog- raphy-guided cardioversion: Assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study. Eur Heart J. 2006;27(23): 2858-2865. 148. de Luca I, Sorino M, De Luca L, Colonna P, Del Salvatore B, Corlian L. Pre- and post-cardioversion transesopha- geal echocardiography for brief anticoagulation therapy with enoxaparin in atrial brillation patients: a prospective study with a 1-year follow-up. Int J Cardiol. 2005;102(3): 447-454. 149. Wu LA, Chandrasekaran K, Friedman PA, et al. Safety of expedited anticoagulation in patients undergoing transesoph- ageal echocardiographic-guided cardioversion. Am J Med. 2006;119(2):142-146. 150. Stellbrink C, Nixdorff U, Hofmann T, et al; ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group. Safety and ef cacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for pre- vention of thromboembolic complications in cardioversion of nonvalvular atrial brillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation. 2004;109(8):997-1003. 151. Stangier J. Clinical pharmacokinetics and pharmacody- namics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet. 2008;47(5):285-295. 122. Wallentin L, Becker RC, Budaj A, et al; PLATO Investi- gators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045-1057. 123. Holmes DR Jr, Kereiakes DJ, Garg S, et al. Stent thrombo- sis. J Am Coll Cardiol. 2010;56(17):1357-1365. 124. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502. 125. Sherman DG, Kim SG, Boop BS, et al; National Heart, Lung, and Blood Institute AFFIRM Investigators. Occur- rence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study. Arch Intern Med. 2005; 165(10):1185-1191. 126. 